Shionogi & Co Ltd 2016 Integrated Report
The report describes Shionogi's fiscal 2015 performance, including record net sales of ¥310.0 billion and operating income of ¥91.4 billion. It highlights progress in SGS2020, growth in HIV franchise royalty income, and a pipeline spanning infectious diseases and pain/CNS. The company reports diversity initiatives, including its first female director and rising female-management ratio. It also details the Mother to Mother SHIONOGI Project and environmental results, including a 27% CO2 reduction versus the benchmark year.
Company: Shionogi & Co Ltd
Sector: Manufacturing
Country: Japan
Year: 2016
Type: Integrated Report
Pages: 80
Back to company
Shionogi & Co Ltd
Integrated Report
The report describes Shionogi's fiscal 2015 performance, including record net sales of ¥310.0 billion and operating income of ¥91.4 billion. It highlights progress in SGS2020, growth in HIV franchise royalty income, and a pipeline spanning infectious diseases and pain/CNS. The company reports diversity initiatives, including its first female director and rising female-management ratio. It also details the Mother to Mother SHIONOGI Project and environmental results, including a 27% CO2 reduction versus the benchmark year.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2016
Reporting Period
Apr 1, 2015 - Mar 31, 2016
Fiscal Year
2015
Type
Integrated Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Total Waste
Women on Board
Women in Management
Employees